Quality of life on TSU‐68: Combination of docetaxel and TSU‐68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

Related Topics

    loading  Loading Related Articles